Genetronhealth China

Genetron
Website:
www.g
Company Size (Fulltime employees)
Please specify your partnering goal
visiting
Headquartner in China
Ms. Yeqing Tan
Marketing 

Genscript Biotech Corp United States

Founded in 2002, GenScript is committed to making humans and environment healthier through innovation. With its over 3,000 employees globally and R&D centers in the U.S., China and Europe, GenScript has become a global leader in providing research, biologics development services, synthetic biology products as well as a world class leader in cell therapy to help patients conquer serious diseases
Company Size (Fulltime employees)
Year of foundation
2002
Please specify your partnering goal
Strategic Partnership
Headquartner in China
Dr. Zhenyan Yan
VP Corporate Development 
Functionality

GenScript USA United States

Synthetic biology company, DNA cold data storage
Website:
GenScript.com
Company Size (Fulltime employees)
Please specify your partnering goal
Investment for DNA cold data storage
Headquartner in China
Dr. Michael Lau
Director 
Functionality

GF Xinde China

I manage 2 USD funds focus on cross boarder investment strategy, and I sit on the board of Twist Bioscience( NASDAQ: TWST)
Website:
GF Xinde.com
Partnering Objectives
Headquartner in China
Xiaoying Mai
Investment director 

GH Therapeutics China

New drug development
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
wenlian xu
CEO 

GIG China

GIG, one of the leading healthcare investment institute, was founded in Shenzhen in 2001. AUM is RMB ¥20b. It has invested in 80+ healthcare companies. 22 went IPO. GIG has 90+ staff in team with operating offices in Shenzhen, Shanghai, Beijing, Nanjing and Hongkong.

Website:
www.szgig.com
Company Size (Fulltime employees)
Please specify your partnering goal
potential investing targets and collaborations
Headquartner in China
Medtech Development Stage
Denise Chen
Partner 
Functionality

Goodmax Investment

Medical Machine investment
Website:
Goodmax. COM. CN
Partnering Objectives
Headquartner in China
JEFF LIANG
PARTNER 

Grektek United States

The everbeat platform is being offered by Grektek, whose mission is to help dramatically improve cardiac care. We created everbeat to improve our ability to take care of ourselves, especially as we get older, and with a strong focus on heart health. Most existing solutions related to cardiac care are unattractive and cumbersome, and brand the patient as weak or sickly. At Grektek, we designed everbeat to be elegant and simple, allowing patients to take better care of themselves with dignity and comfort. We also believe that patients will enjoy the everbeat solution, which means they will use it consistently for a long time – and sustained use of a cardiac monitoring platform is essential to getting healthy.

Website:
everbeat.org
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
Medical organizations looking to deploy remote patient monitoring solutions that can be proved to help their patients.
Headquartner in China
Biotech/Pharma Category
Assets Information 1
Everbeat Watch|Watch that can take a clinical grade ECG||USA
Biotech/Pharma Asset Stage
Medtech Category
Medtech Information 1
Everbeat | wearable ECG band | USA
Medtech Development Stage
Mr. Greg Eoyang
CTO 
Functionality

Guoqian VC China

Guoqian Medical Technology (Suzhou) Co., Ltd. was registered and established in Suzhou High-tech Zone in 2017.

Guoqian Medical has two business platforms: Guoqian Venture Capital and Guoqian Medical Technology Innovation Research Institute.

Guoqian Venture Capital is a professional and market-oriented venture capital institution that focuses on equity investment in early innovation and entrepreneurship projects in the fields of medical devices, in vitro diagnostic reagents and biotechnology. Focusing on high-end scientific and technological talents with Chinese major talent engineering experts as the core, they seek high-quality investment targets during the transformation of scientific and technological achievements, the introduction of technological projects, the evaluation of innovative and entrepreneurial projects, and the landing of innovative and entrepreneurial projects.

Guoqian Medical Technology Innovation Research Institute is committed to cultivating cutting-edge technologies and projects in the domestic medical device industry, and providing it with multi-faceted technologies, policies, talents, industrialization and markets through direct investment, entrepreneurial services, and scientific and technological achievement transformation services. Integration of services and resources to create an innovative platform for national technological innovation and industrial integration and empowerment. At the same time, it has also become an enabling platform for post-investment enterprises of Guoqian Fund. By creating industrial clusters and industrial ecology, it will provide post-investment management, post-investment services, and post-investment empowerment to post-investment enterprises.

Based on the business philosophy of “achieving the dreams of others”, Guoqian Medical uses market-oriented and specialized equity investment funds to create industrial agglomeration and industrial ecology; it empowers post-investment enterprises by creating industrial agglomeration and industrial ecology. The two platforms complement each other, and strive to build a medical device industry cluster and ecosystem in Suzhou High-tech Zone in 10 years, becoming one of the main promoters of the domestic medical device industry.
Year of foundation
2017
Headquartner in China
Don Lin
Founding Partner 
Functionality
Don Lin
Founding Partning 
Functionality

Guotaijunan security China

Leading Investment and security company in China
Partnering Objectives
Headquartner in China
Zheng Xu
Director